Retiro De Equipo (Recall) de Device Recall EDWARDS AQUARIUS HEMOFILTRATION SYSTEM

Recall

53554

Class 1

Z-0653-2010

2009-03-16

2010-01-27

Terminated

United States

2012-01-18

USFDA

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=85849

There have been reports of clinically significant fluid imbalance when a certain level of fluid imbalance is detected the aquarius will trigger an alarm, however, users are able to override this alarm and continue therapy. it is possible to remove too much fluid from or replace too much fluid to the patient. in extreme cases, this may result in serious injuries or death.

Edwards is continuing a field corrective action related to the possibility of fluid imbalance when using the Aquarius. In order to mitigate some of the risk associated with this problem, Edwards sent notifications to consignees advising of mitigation steps. Consignees were provided: a description of the affected product, problem, and potential hazard; advice on action to be taken; and revised device labeling. Additionally, consignees were notified of a planned software upgrade to prevent users from bypassing the fluid balance alarm more than five times in a 20-minute period. Although Edwards does not believe there is a need to stop using the Aquarius system at this time, clinicians should weigh the risks/benefits to the patients before continuing the use of the device Edwards first provided some of this information to consignees in a Field Safety Notice on March 16, 2009. On January 11, 2010, Edwards provided an Urgent Product Recall letter to consignees which updated and expanded the earlier communication. The FDA classified this as a Class I recall.